Annual EPS
-$1.73
+$3.98+69.70%
March 1, 2024
Summary
- As of February 8, 2025, GRCE annual earnings per share is -$1.73, with the most recent change of +$3.98 (+69.70%) on March 1, 2024.
- During the last 3 years, GRCE annual EPS has risen by +$6.25 (+78.32%).
- GRCE annual EPS is now -6.79% below its all-time high of -$1.62, reached on March 1, 2022.
Performance
GRCE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$0.30
-$0.06-25.00%
September 1, 2024
Summary
- As of February 8, 2025, GRCE quarterly earnings per share is -$0.30, with the most recent change of -$0.06 (-25.00%) on September 1, 2024.
- Over the past year, GRCE quarterly EPS has increased by +$0.02 (+7.66%).
- GRCE quarterly EPS is now -102.56% below its all-time high of $11.73, reached on November 1, 2014.
Performance
GRCE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$1.29
+$0.13+9.13%
September 1, 2024
Summary
- As of February 8, 2025, GRCE TTM earnings per share is -$1.29, with the most recent change of +$0.13 (+9.13%) on September 1, 2024.
- Over the past year, GRCE TTM EPS has increased by +$3.91 (+75.13%).
- GRCE TTM EPS is now -143.15% below its all-time high of $3.00, reached on December 1, 2020.
Performance
GRCE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
GRCE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +69.7% | +7.7% | +75.1% |
| 3 y3 years | +78.3% | +54.5% | +44.6% |
| 5 y5 years | +95.1% | +97.5% | +80.7% |
GRCE EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.8% | +78.3% | -25.0% | +92.3% | at high | +77.3% |
| 5 y | 5-year | -6.8% | +95.1% | -103.0% | +95.5% | -143.2% | +96.0% |
| alltime | all time | -6.8% | +97.1% | -102.6% | +99.7% | -143.2% | +99.0% |
Grace Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$0.30(+25.0%) | -$1.29(-9.1%) |
| Jun 2024 | - | -$0.24(-44.1%) | -$1.42(-17.4%) |
| Mar 2024 | -$1.73(-69.7%) | -$0.43(+32.3%) | -$1.72(-66.9%) |
| Dec 2023 | - | -$0.32(-24.4%) | -$5.20(-3.6%) |
| Sep 2023 | - | -$0.43(-20.4%) | -$5.40(-4.1%) |
| Jun 2023 | - | -$0.54(-86.2%) | -$5.63(-1.2%) |
| Mar 2023 | -$5.71(+252.5%) | -$3.91(+651.9%) | -$5.70(+145.8%) |
| Dec 2022 | - | -$0.52(-21.2%) | -$2.32(-0.9%) |
| Sep 2022 | - | -$0.66(+8.2%) | -$2.34(+56.0%) |
| Jun 2022 | - | -$0.61(+15.3%) | -$1.50(-6.8%) |
| Mar 2022 | -$1.62(-79.7%) | -$0.53(-2.1%) | -$1.61(-32.4%) |
| Dec 2021 | - | -$0.54(-400.0%) | -$2.38(-30.0%) |
| Sep 2021 | - | $0.18(-125.0%) | -$3.40(-49.2%) |
| Jun 2021 | - | -$0.72(-44.6%) | -$6.70(-20.0%) |
| Mar 2021 | -$7.98(-44.6%) | -$1.30(-16.6%) | -$8.38(-379.4%) |
| Dec 2020 | - | -$1.56(-50.0%) | $3.00(-238.9%) |
| Sep 2020 | - | -$3.12(+30.0%) | -$2.16(-80.4%) |
| Jun 2020 | - | -$2.40(-123.8%) | -$11.04(-20.7%) |
| Mar 2020 | -$14.40(-58.9%) | $10.08(-250.0%) | -$13.92(-57.3%) |
| Dec 2019 | - | -$6.72(-44.0%) | -$32.61(+15.0%) |
| Sep 2019 | - | -$12.00(+127.3%) | -$28.36(-28.0%) |
| Jun 2019 | - | -$5.28(-38.7%) | -$39.39(-7.3%) |
| Mar 2019 | -$35.04(-23.4%) | -$8.61(+249.0%) | -$42.50(-6.1%) |
| Dec 2018 | - | -$2.47(-89.3%) | -$45.26(-22.0%) |
| Sep 2018 | - | -$23.03(+174.4%) | -$58.06(+23.5%) |
| Jun 2018 | - | -$8.39(-26.1%) | -$47.02(+3.0%) |
| Mar 2018 | -$45.72(+25.8%) | -$11.36(-25.6%) | -$45.64(+33.2%) |
| Dec 2017 | - | -$15.27(+27.3%) | -$34.28(+27.6%) |
| Sep 2017 | - | -$11.99(+71.1%) | -$26.87(+17.1%) |
| Jun 2017 | - | -$7.01(-10.8%) | -$22.94(-30.0%) |
| Mar 2017 | -$36.35 | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2016 | - | -$7.86(-2.6%) | -$32.78(+1.0%) |
| Aug 2016 | - | -$8.07(-24.4%) | -$32.46(+12.9%) |
| May 2016 | - | -$10.67(+72.7%) | -$28.74(+33.4%) |
| Feb 2016 | -$20.90(+240.5%) | -$6.18(-18.0%) | -$21.54(-10.3%) |
| Nov 2015 | - | -$7.54(+73.3%) | -$24.02(+406.2%) |
| Aug 2015 | - | -$4.35(+25.1%) | -$4.74(-65.2%) |
| May 2015 | - | -$3.48(-59.8%) | -$13.64(+137.7%) |
| Feb 2015 | -$6.14(-89.7%) | -$8.65(-173.7%) | -$5.74(+142.6%) |
| Nov 2014 | - | $11.73(-188.6%) | -$2.37(-93.6%) |
| Aug 2014 | - | -$13.24(-399.4%) | -$36.70(-11.9%) |
| May 2014 | - | $4.42(-183.8%) | -$41.67(-30.6%) |
| Feb 2014 | -$59.53(+41.1%) | -$5.28(-76.6%) | -$60.07(-4.9%) |
| Nov 2013 | - | -$22.61(+24.1%) | -$63.16(+25.8%) |
| Aug 2013 | - | -$18.21(+30.4%) | -$50.22(+20.5%) |
| May 2013 | - | -$13.97(+66.9%) | -$41.68(+12.6%) |
| Feb 2013 | -$42.20(-12.6%) | -$8.37(-13.4%) | -$37.02(-6.8%) |
| Nov 2012 | - | -$9.66(-0.0%) | -$39.74(-9.7%) |
| Aug 2012 | - | -$9.67(+3.8%) | -$44.02(-10.3%) |
| May 2012 | - | -$9.32(-16.0%) | -$49.06(-0.8%) |
| Feb 2012 | -$48.28(+65.6%) | -$11.09(-20.5%) | -$49.48(+1.2%) |
| Nov 2011 | - | -$13.95(-5.2%) | -$48.89(+20.6%) |
| Aug 2011 | - | -$14.71(+51.2%) | -$40.55(+33.7%) |
| May 2011 | - | -$9.73(-7.4%) | -$30.32(+20.6%) |
| Feb 2011 | -$29.15(-8.8%) | -$10.51(+87.6%) | -$25.14(+40.8%) |
| Nov 2010 | - | -$5.60(+25.0%) | -$17.85(-16.3%) |
| Aug 2010 | - | -$4.48(-1.5%) | -$21.33(-45.0%) |
| May 2010 | - | -$4.55(+41.3%) | -$38.76(-18.3%) |
| Feb 2010 | -$31.97 | -$3.22(-64.5%) | -$47.42(+7.3%) |
| Nov 2009 | - | -$9.08(-58.6%) | -$44.20(-65.4%) |
| Aug 2009 | - | -$21.91(+65.9%) | -$127.88(+20.7%) |
| May 2009 | - | -$13.21(-85.8%) | -$105.97(+14.2%) |
| Nov 2008 | - | -$92.76 | -$92.76 |
FAQ
- What is Grace Therapeutics annual earnings per share?
- What is the all time high annual EPS for Grace Therapeutics?
- What is Grace Therapeutics annual EPS year-on-year change?
- What is Grace Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Grace Therapeutics?
- What is Grace Therapeutics quarterly EPS year-on-year change?
- What is Grace Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Grace Therapeutics?
- What is Grace Therapeutics TTM EPS year-on-year change?
What is Grace Therapeutics annual earnings per share?
The current annual EPS of GRCE is -$1.73
What is the all time high annual EPS for Grace Therapeutics?
Grace Therapeutics all-time high annual earnings per share is -$1.62
What is Grace Therapeutics annual EPS year-on-year change?
Over the past year, GRCE annual earnings per share has changed by +$3.98 (+69.70%)
What is Grace Therapeutics quarterly earnings per share?
The current quarterly EPS of GRCE is -$0.30
What is the all time high quarterly EPS for Grace Therapeutics?
Grace Therapeutics all-time high quarterly earnings per share is $11.73
What is Grace Therapeutics quarterly EPS year-on-year change?
Over the past year, GRCE quarterly earnings per share has changed by +$0.02 (+7.66%)
What is Grace Therapeutics TTM earnings per share?
The current TTM EPS of GRCE is -$1.29
What is the all time high TTM EPS for Grace Therapeutics?
Grace Therapeutics all-time high TTM earnings per share is $3.00
What is Grace Therapeutics TTM EPS year-on-year change?
Over the past year, GRCE TTM earnings per share has changed by +$3.91 (+75.13%)